Laurus Labs share price at record high after Q2 results 2026, dividend announcement – Should you buy pharma stock?
Laurus Labs shares hit a record high after Q2FY27 revenue rose 33% and net profit jumped 126%. The company declared an interim dividend and expanded peptide manufacturing. While brokerages recognized growth prospects, they urged investors to weigh potential against the…
Read the full story at source →
Post Comment